SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system long after infection. Researchers now link symptoms to lingering virus, ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Anticoagulation and/or antiplatelet therapy with a variety of agents does not prevent acute ...

Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial.

Post-COVID-19 condition (PCC) involves persistent symptoms like fatigue and cognitive dysfunction, affecting 8.4% of US adults. A randomized clinical trial showed cognitive and behavioral ...

NEW YORK CITY (WABC) -- A 16-year-old girl who tested positive for COVID-19 and whose condition was deteriorating was successfully treated with a blood-cleaning procedure and is now recovering at home ...

Samantha Chatman (WLS) -- While many people are finding ways to manage the effects of COVID-19, others are finding it hard to cope with this new normal. With so much uncertainty, local therapists are ...

Even as the acute phase of the COVID-19 pandemic fades, the world continues to wrestle with its aftermath — and nowhere is that more evident than in the enduring challenge of Long COVID. The condition ...